Afilin-200

Product Composition

Each film-coated sustained-release tablet contains:

• Acebrophylline (200 mg): A therapeutic agent with dual bronchodilator and mucolytic properties.

• Excipients: Sufficient quantities used for tablet formulation.

• Color: Titanium Dioxide IP.

Product Summary

Afilin-200 is a respiratory medication marketed by Healthgate Pvt. Ltd. It is primarily used to treat and prevent symptoms of chronic obstructive pulmonary disease (COPD) and asthma. It works by relaxing the muscles in the airways and thinning the mucus in the lungs, making it easier for the patient to breathe. As a “Sustained Release” tablet, it is designed to release the medication slowly into the bloodstream over an extended period.

Pros and Cons

Pros

• Dual Action: Effectively manages both airway constriction and thick mucus buildup.

• Sustained Relief: The 200 mg sustained-release formula reduces the frequency of dosing required throughout the day.

• Improved Airflow: Helps reduce shortness of breath and wheezing associated with chronic respiratory conditions.

Cons

• Gastrointestinal Issues: May cause nausea, vomiting, or abdominal discomfort in some users.

• Nervous System Effects: Potential side effects include dizziness or headaches.

• Specific Restrictions: Not suitable for patients with low blood pressure, heart rhythm disorders, or those who have recently suffered a heart attack.

How to Use

• Administration: Swallow the tablet whole with a glass of water. Do not crush or chew the tablet, as this will destroy the sustained-release mechanism.

• Timing: Usually taken once or twice daily, or as specifically directed by a healthcare professional.

• Food: Can typically be taken with or without food, but taking it after a meal may help reduce potential stomach upset.

• Storage: Store in a cool, dry place, protected from light and moisture, at a temperature not exceeding 30°C.

Warning: This is a Schedule H Prescription Drug. It should only be used under the guidance of a registered medical practitioner.